Early Movers: TetraLogic (TLOG), ITT Educational Services (ESI), Biocept (BIOC), MBIA (MBI), WPCS Int’l (WPCS)

TetraLogic Pharmaceuticals Corporation (TLOG) shares surged more than 55 percent on Wednesday after news of positive preliminary data from its ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes.

“While acknowledging the small number of patients involved in the study, we find these data encouraging,” commented Dr. Lesley Russell, TetraLogic’s Chief Medical Officer. “We plan to conduct an interim analysis of the ongoing randomized trial around the end of the year and look forward to reviewing those results.”

ITT Educational Services Inc. (ESI) shares gained 15.37% to $4.59 in early trading following the company’s submission of audited consolidated financial statements to the U.S. Department of Education on June 26, 2015, ahead of the June 30 due date.

Shares of Biocept, Inc. (BIOC) are higher by nearly 15% to $2.92 in morning trading on Wednesday after the molecular diagnostics company announced the launch of its FGFR1 amplification testing utilizing a patient’s blood sample.

Shares of MBIA Inc. (MBI) are up more than 3% this morning after a WaPo report suggested that debt-ridden Puerto Rican utility PREPA is close to a deal with creditors to avoid a default. MBI has exposure to Puerto Rican debt.

If the deal is reached, it would effectively give the PREPA, which has about $9 billion in debt, another 90 days to reach agreement on a broader restructuring of its finances.

WPCS International Incorporated (WPCS) shares surged 69% to $2.60 in early trading. The company today announced that it was awarded $3.6 million in new contracts during the first two months of fiscal year 2016.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.